Press Release: Lazar Partners : WATS3D Markedly Improves Detection of Esophageal Dysplasia and Barrett's Esophagus in 12,899 Patient Study in the "Real World" Practice setting of 58 Community-Based Gastroenterologists

CDx Diagnostics today announced the publication of new data demonstrating that the addition of WATS3D (Wide Area Transepithelial Sampling with 3D Tissue Analysis) to standard targeted and random forceps biopsy (FB) markedly increases the overall detection of esophageal dysplasia (ED) by 242% and the overall detection of Barrett’s esophagus (BE) by 153% in patients undergoing BE screening